Literature DB >> 23829238

Rebound of disease activity during pregnancy after withdrawal of fingolimod.

A P Sempere, L Berenguer-Ruiz, E Feliu-Rey.   

Abstract

Entities:  

Keywords:  fingolimod; multiple sclerosis; pregnancy; therapy

Mesh：

Substances：

Year:  2013        PMID： 23829238     DOI： 10.1111/ene.12195

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN： 1351-5101            Impact factor:   6.089


× No keyword cloud information.
  19 in total

1.  Multiple sclerosis rebound after fingolimod discontinuation for lymphopenia.

Authors:  Loredana La Mantia; Valentina Prone; Maria Raffaella Marazzi; Cristina Erminio; Alessandra Protti
Journal:  Neurol Sci       Date:  2014-04-23       Impact factor: 3.307

Review 2.  Multiple sclerosis and pregnancy in the 'treatment era'.

Authors:  Sandra Vukusic; Romain Marignier
Journal:  Nat Rev Neurol       Date:  2015-04-21       Impact factor: 42.937

3.  Relapses and obstetric outcomes in women with multiple sclerosis planning pregnancy.

Authors:  Leticia Berenguer-Ruiz; Juana Gimenez-Martinez; Antonio Palazón-Bru; Angel Perez Sempere
Journal:  J Neurol       Date:  2019-06-29       Impact factor: 4.849

Review 4.  Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis.

Authors:  Alberto Gajofatto; Marco Turatti; Salvatore Monaco; Maria Donata Benedetti
Journal:  Drug Healthc Patient Saf       Date:  2015-12-11

Review 5.  Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations.

Authors:  Ilya Ayzenberg; Robert Hoepner; Ingo Kleiter
Journal:  Ther Clin Risk Manag       Date:  2016-02-19       Impact factor: 2.423

Review 6.  Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks.

Authors:  Raed Alroughani; Ayse Altintas; Mohammed Al Jumah; Mohammadali Sahraian; Issa Alsharoqi; Abdurahman AlTahan; Abdulkader Daif; Maurice Dahdaleh; Dirk Deleu; Oscar Fernandez; Nikolaos Grigoriadis; Jihad Inshasi; Rana Karabudak; Karim Taha; Natalia Totolyan; Bassem I Yamout; Magd Zakaria; Saeed Bohlega
Journal:  Mult Scler Int       Date:  2016-12-18

7.  Dramatic rebounds of MS during pregnancy following fingolimod withdrawal.

Authors:  Giovanni Novi; Angelo Ghezzi; Matteo Pizzorno; Caterina Lapucci; Fabio Bandini; Pietro Annovazzi; Giovanni L Mancardi; Antonio Uccelli
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-07-27

Review 8.  Neurological safety of fingolimod: An updated review.

Authors:  Fumihito Yoshii; Yusuke Moriya; Tomohide Ohnuki; Masafuchi Ryo; Wakoh Takahashi
Journal:  Clin Exp Neuroimmunol       Date:  2017-06-18

9.  Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD.

Authors:  Gitanjali Das; Vincent Damotte; Jeffrey M Gelfand; Carolyn Bevan; Bruce A C Cree; Lynn Do; Ari J Green; Stephen L Hauser; Riley Bove
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-03-19

10.  A comparison of multiple sclerosis disease activity after discontinuation of fingolimod and placebo.

Authors:  Patrick Vermersch; Ernst-Wilhelm Radue; Norman Putzki; Shannon Ritter; Martin Merschhemke; Mark S Freedman
Journal:  Mult Scler J Exp Transl Clin       Date:  2017-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.